All data are based on the daily closing price as of March 2, 2026
t

Towa Pharmaceutical

4553.TSE
27.97 USD
-0.26
-0.92%

Overview

Last close
27.97 usd
Market cap
1.38B usd
52 week high
28.23 usd
52 week low
16.24 usd
Target price
24.75 usd

Valuation

P/E
8.8666
Forward P/E
16.7785
Price/Sales
0.8079
Price/Book Value
1.1445
Enterprise Value
2.62B usd
EV/Revenue
1.541
EV/EBITDA
7.9964

Key financials

Revenue TTM
1.70B usd
Gross Profit TTM
618.80M usd
EBITDA TTM
284.32M usd
Earnings per Share
2.68 usd
Dividend
0.51 usd
Total assets
3.12B usd
Net debt
1.24B usd

About

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sale ethical drugs in Japan. It operates through two segments; Domestic and Overseas. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products, as well as provide formulations from Tablets, Capsules, Injectable, Patches, eye drops, and other products. It also offers IT service related to healthcare; disease risk testing services; and quasi drugs. In addition, the company is involved in research and development and production of active pharmaceutical ingredients, intermediates, support business; and planning, development and OEM manufacturing of health foods, pharmaceuticals, general foods, and other miscellaneous merchandizes. The company was founded in 1951 and is headquartered in Osaka, Japan.
  • Symbol
    4553.TSE
  • Exchange
    TSE
  • Isin
    JP3623150004
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
  • Headquarter
    Osaka
  • Web site
    https://www.towayakuhin.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top